Rapid Relief of Rhinitis with R112

Novel Therapy May Impact a Congested Market
Emerging Technologies


Allergic Rhinitis Montelukast Triamcinolone Acetonide Seasonal Allergic Rhinitis Desloratadine 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


  1. 1.
    Meltzer EO, Berkowitz RB, Grossbard EB. An intranasal Syk-kinase inhibitor (R112) improves the symptoms of seasonal allergic rhinitis in a park environment. J Allergy Clin Immunol 2005; 115 (4): 791–6PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2005

Personalised recommendations